PL2391352T3 - Formy farmaceutyczne stosowane do uwalniania związków aktywnych - Google Patents
Formy farmaceutyczne stosowane do uwalniania związków aktywnychInfo
- Publication number
- PL2391352T3 PL2391352T3 PL10702287T PL10702287T PL2391352T3 PL 2391352 T3 PL2391352 T3 PL 2391352T3 PL 10702287 T PL10702287 T PL 10702287T PL 10702287 T PL10702287 T PL 10702287T PL 2391352 T3 PL2391352 T3 PL 2391352T3
- Authority
- PL
- Poland
- Prior art keywords
- release
- active compounds
- pharmaceutical forms
- pharmaceutical
- forms
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2063—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09382014A EP2213282A1 (en) | 2009-01-30 | 2009-01-30 | Pharmaceutical forms for the release of active compounds |
| PCT/EP2010/051127 WO2010086425A1 (en) | 2009-01-30 | 2010-01-29 | Pharmaceutical forms for the release of active compounds |
| EP10702287.3A EP2391352B1 (en) | 2009-01-30 | 2010-01-29 | Pharmaceutical forms for the release of active compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2391352T3 true PL2391352T3 (pl) | 2018-05-30 |
Family
ID=40602343
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10702287T PL2391352T3 (pl) | 2009-01-30 | 2010-01-29 | Formy farmaceutyczne stosowane do uwalniania związków aktywnych |
Country Status (11)
| Country | Link |
|---|---|
| EP (2) | EP2213282A1 (pl) |
| CY (1) | CY1120050T1 (pl) |
| DK (1) | DK2391352T3 (pl) |
| ES (1) | ES2655689T3 (pl) |
| HR (1) | HRP20180103T1 (pl) |
| HU (1) | HUE037915T2 (pl) |
| LT (1) | LT2391352T (pl) |
| PL (1) | PL2391352T3 (pl) |
| PT (1) | PT2391352T (pl) |
| SI (1) | SI2391352T1 (pl) |
| WO (2) | WO2010086425A1 (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102120781B (zh) * | 2011-03-16 | 2013-07-17 | 中国药科大学 | 一种新型胰岛素口服纳米粒的制备及应用 |
| CN108668349B (zh) | 2011-04-01 | 2021-07-02 | 三菱电机株式会社 | 通信系统 |
| EP3273239A1 (en) | 2016-07-19 | 2018-01-24 | Laboratorios Farmacéuticos Rovi, S.A. | Procedure of analysis of glycosaminoglycans, heparins and their derivatives by nuclear magnetic resonance |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3482014A (en) | 1966-06-29 | 1969-12-02 | Canada Packers Ltd | Orally active heparin and method for making and using same |
| US4703042A (en) | 1984-05-21 | 1987-10-27 | Bodor Nicholas S | Orally active heparin salts containing multivalent cationic units |
| US4925677A (en) * | 1988-08-31 | 1990-05-15 | Theratech, Inc. | Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents |
| US6582728B1 (en) | 1992-07-08 | 2003-06-24 | Inhale Therapeutic Systems, Inc. | Spray drying of macromolecules to produce inhaleable dry powders |
| FR2811227A1 (fr) * | 2000-07-07 | 2002-01-11 | Philippe Maincent | Vecteurs particulaires destines a ameliorer l'absorption orale de principes actifs |
| ITMI20012599A1 (it) | 2001-12-11 | 2003-06-11 | Cosmo Spa | Composizioni farmaceutiche per la somministrazione orale di eparina osuoi derivati, utili per la terapia di malattie infiammatorie dell'int |
| WO2003094887A1 (en) * | 2002-05-09 | 2003-11-20 | Peptron Co., Ltd | Sustained release formulation of protein and preparation method thereof |
| GB0310919D0 (en) * | 2003-05-13 | 2003-06-18 | West Pharm Serv Drug Res Ltd | Pharmaceutical compositions |
| ES2222822B1 (es) | 2003-07-28 | 2005-12-16 | Laboratorios Farmaceuticos Rovi, S.A. | Diamidas de aminoacidos en posicion no alfa utiles como adyuvantes para la administracion de agentes biologicos activos. |
| ES2286674T3 (es) * | 2003-10-01 | 2007-12-01 | Debio Recherche Pharmaceutique S.A. | Dispositivo y procedimiento para la fabricacion de particulas. |
| US7556826B2 (en) * | 2005-01-04 | 2009-07-07 | Gp Medical, Inc. | Nanoparticles for protein drug delivery |
| US20070154546A1 (en) | 2005-12-30 | 2007-07-05 | Zhang Jack Y | Sustained release pharmaceutical compositions |
| ES2296529B1 (es) | 2006-08-07 | 2009-04-01 | Laboratorios Farmaceuticos Rovi, S.A. | Composicion farmaceutica con promotores de absorcion. |
-
2009
- 2009-01-30 EP EP09382014A patent/EP2213282A1/en not_active Withdrawn
-
2010
- 2010-01-29 PL PL10702287T patent/PL2391352T3/pl unknown
- 2010-01-29 PT PT107022873T patent/PT2391352T/pt unknown
- 2010-01-29 LT LTEP10702287.3T patent/LT2391352T/lt unknown
- 2010-01-29 HU HUE10702287A patent/HUE037915T2/hu unknown
- 2010-01-29 SI SI201031619T patent/SI2391352T1/en unknown
- 2010-01-29 WO PCT/EP2010/051127 patent/WO2010086425A1/en active Application Filing
- 2010-01-29 WO PCT/EP2010/051129 patent/WO2010086427A1/en active Application Filing
- 2010-01-29 ES ES10702287.3T patent/ES2655689T3/es active Active
- 2010-01-29 DK DK10702287.3T patent/DK2391352T3/da active
- 2010-01-29 EP EP10702287.3A patent/EP2391352B1/en active Active
-
2018
- 2018-01-16 CY CY20181100045T patent/CY1120050T1/el unknown
- 2018-01-19 HR HRP20180103TT patent/HRP20180103T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CY1120050T1 (el) | 2018-12-12 |
| ES2655689T3 (es) | 2018-02-21 |
| SI2391352T1 (en) | 2018-04-30 |
| WO2010086427A1 (en) | 2010-08-05 |
| HUE037915T2 (hu) | 2018-09-28 |
| PT2391352T (pt) | 2018-01-19 |
| WO2010086425A1 (en) | 2010-08-05 |
| EP2391352A1 (en) | 2011-12-07 |
| DK2391352T3 (da) | 2018-01-29 |
| HRP20180103T1 (hr) | 2018-04-20 |
| LT2391352T (lt) | 2018-05-25 |
| EP2213282A1 (en) | 2010-08-04 |
| EP2391352B1 (en) | 2017-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL238337A0 (en) | A process for the preparation of pharmaceutical active compounds | |
| EP2566334A4 (en) | SOLID MEDIA FOR THE CONTROLLED RELEASE OF MEDICAMENTS | |
| GB201008005D0 (en) | Pharmaceutical compounds | |
| EP2500038A4 (en) | PHATMACEUTICAL COMPOSITION FOR EXTERNAL USE / | |
| IL201465A0 (en) | Self-precipitating pharmaceutical formulations for the modified release of active principle | |
| PL2554168T3 (pl) | Kompozycja farmaceutyczna do kontrolowanego uwalniania | |
| GB201020161D0 (en) | Pharmaceutical compounds | |
| GB0922589D0 (en) | Pharmaceutical compounds | |
| HUE037915T2 (hu) | Gyógyszerészeti készítmények aktív vegyületek felszabadítására | |
| HRP20130805T2 (en) | Granulate for the formulation of orodispersible tablets | |
| GB0908905D0 (en) | Pharmaceutical compounds | |
| GB0917775D0 (en) | Novel pharmaceutical compounds | |
| SI2219611T1 (sl) | Farmacevtske oblike za sproĺ äśanje aktivnih spojin | |
| EP2473168A4 (en) | PHARMACEUTICAL FORMULATIONS FOR INDIBULIN | |
| GB0917774D0 (en) | Novel pharmaceutical compounds | |
| GB0904311D0 (en) | Processes for the preparation of compounds | |
| GB0915678D0 (en) | Pharmaceutical compounds | |
| GB0911699D0 (en) | Pharmaceutical compounds | |
| GB0913850D0 (en) | Pharmaceutical compounds | |
| GB0916458D0 (en) | Pharmaceutical compounds | |
| GB0917677D0 (en) | Pharmaceutical compounds | |
| GB0922523D0 (en) | Pharmaceutical compounds | |
| EP2276476A4 (en) | MANUFACTURING PROCESS FOR THERMOSTANGE FOR ACTIVE INGREDIENT EXTRACTION FROM THE THERMOSTANGE | |
| IL223324A (en) | Pharmaceutical compounds | |
| GB0914989D0 (en) | Drug release formulations |